These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 16596198

  • 1. Aberrant methylation of RASGRF2 and RASSF1A in human non-small cell lung cancer.
    Chen H, Suzuki M, Nakamura Y, Ohira M, Ando S, Iida T, Nakajima T, Nakagawara A, Kimura H.
    Oncol Rep; 2006 May; 15(5):1281-5. PubMed ID: 16596198
    [Abstract] [Full Text] [Related]

  • 2. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas.
    Virmani AK, Rathi A, Sathyanarayana UG, Padar A, Huang CX, Cunnigham HT, Farinas AJ, Milchgrub S, Euhus DM, Gilcrease M, Herman J, Minna JD, Gazdar AF.
    Clin Cancer Res; 2001 Jul; 7(7):1998-2004. PubMed ID: 11448917
    [Abstract] [Full Text] [Related]

  • 3. Critical role of deltaDNMT3B4/2 in regulating RASSF1A promoter-specific DNA methylation in non-small cell lung cancer.
    Wang SH, Liu NH, Wang J, Bai H, Mao L.
    Chin Med J (Engl); 2008 Sep 05; 121(17):1712-21. PubMed ID: 19024105
    [Abstract] [Full Text] [Related]

  • 4. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas.
    Toyooka KO, Toyooka S, Virmani AK, Sathyanarayana UG, Euhus DM, Gilcrease M, Minna JD, Gazdar AF.
    Cancer Res; 2001 Jun 01; 61(11):4556-60. PubMed ID: 11389090
    [Abstract] [Full Text] [Related]

  • 5. Expression of Delta DNMT3B variants and its association with promoter methylation of p16 and RASSF1A in primary non-small cell lung cancer.
    Wang J, Walsh G, Liu DD, Lee JJ, Mao L.
    Cancer Res; 2006 Sep 01; 66(17):8361-6. PubMed ID: 16951144
    [Abstract] [Full Text] [Related]

  • 6. Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.
    Agathanggelou A, Dallol A, Zöchbauer-Müller S, Morrissey C, Honorio S, Hesson L, Martinsson T, Fong KM, Kuo MJ, Yuen PW, Maher ER, Minna JD, Latif F.
    Oncogene; 2003 Mar 13; 22(10):1580-8. PubMed ID: 12629521
    [Abstract] [Full Text] [Related]

  • 7. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
    Yanagawa N, Tamura G, Oizumi H, Kanauchi N, Endoh M, Sadahiro M, Motoyama T.
    Lung Cancer; 2007 Oct 13; 58(1):131-8. PubMed ID: 17606310
    [Abstract] [Full Text] [Related]

  • 8. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
    Byun DS, Lee MG, Chae KS, Ryu BG, Chi SG.
    Cancer Res; 2001 Oct 01; 61(19):7034-8. PubMed ID: 11585730
    [Abstract] [Full Text] [Related]

  • 9. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.
    Lee MG, Kim HY, Byun DS, Lee SJ, Lee CH, Kim JI, Chang SG, Chi SG.
    Cancer Res; 2001 Sep 15; 61(18):6688-92. PubMed ID: 11559536
    [Abstract] [Full Text] [Related]

  • 10. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
    Sato M, Horio Y, Sekido Y, Minna JD, Shimokata K, Hasegawa Y.
    Oncogene; 2002 Jul 18; 21(31):4822-9. PubMed ID: 12101420
    [Abstract] [Full Text] [Related]

  • 11. Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines.
    Harada K, Toyooka S, Maitra A, Maruyama R, Toyooka KO, Timmons CF, Tomlinson GE, Mastrangelo D, Hay RJ, Minna JD, Gazdar AF.
    Oncogene; 2002 Jun 20; 21(27):4345-9. PubMed ID: 12082624
    [Abstract] [Full Text] [Related]

  • 12. Clinicopathological significance of aberrant methylation of RARbeta2 at 3p24, RASSF1A at 3p21.3, and FHIT at 3p14.2 in patients with non-small cell lung cancer.
    Tomizawa Y, Iijima H, Nomoto T, Iwasaki Y, Otani Y, Tsuchiya S, Saito R, Dobashi K, Nakajima T, Mori M.
    Lung Cancer; 2004 Dec 20; 46(3):305-12. PubMed ID: 15541815
    [Abstract] [Full Text] [Related]

  • 13. Hypermethylation of the GATA genes in lung cancer.
    Guo M, Akiyama Y, House MG, Hooker CM, Heath E, Gabrielson E, Yang SC, Han Y, Baylin SB, Herman JG, Brock MV.
    Clin Cancer Res; 2004 Dec 01; 10(23):7917-24. PubMed ID: 15585625
    [Abstract] [Full Text] [Related]

  • 14. Epigenetic inactivation of the RUNX3 gene in lung cancer.
    Sato K, Tomizawa Y, Iijima H, Saito R, Ishizuka T, Nakajima T, Mori M.
    Oncol Rep; 2006 Jan 01; 15(1):129-35. PubMed ID: 16328045
    [Abstract] [Full Text] [Related]

  • 15. [Analysis of RASSF1A promoter hypermethylation in serum DNA of non-small cell lung cancer].
    Yu ZH, Wang YC, Chen LB, Song Y, Liu C, Xia XY, Lin Q, Ma CY.
    Zhonghua Zhong Liu Za Zhi; 2008 Apr 01; 30(4):284-7. PubMed ID: 18788633
    [Abstract] [Full Text] [Related]

  • 16. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y, Brena RM, Hackanson B, Morrison C, Otterson GA, Plass C.
    J Natl Cancer Inst; 2006 Mar 15; 98(6):396-406. PubMed ID: 16537832
    [Abstract] [Full Text] [Related]

  • 17. Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas.
    Heller G, Fong KM, Girard L, Seidl S, End-Pfützenreuter A, Lang G, Gazdar AF, Minna JD, Zielinski CC, Zöchbauer-Müller S.
    Oncogene; 2006 Feb 09; 25(6):959-68. PubMed ID: 16205641
    [Abstract] [Full Text] [Related]

  • 18. The correlation between aberrant connexin 43 mRNA expression induced by promoter methylation and nodal micrometastasis in non-small cell lung cancer.
    Chen JT, Cheng YW, Chou MC, Sen-Lin T, Lai WW, Ho WL, Lee H.
    Clin Cancer Res; 2003 Sep 15; 9(11):4200-4. PubMed ID: 14519646
    [Abstract] [Full Text] [Related]

  • 19. Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer.
    Kuroki T, Trapasso F, Yendamuri S, Matsuyama A, Alder H, Williams NN, Kaiser LR, Croce CM.
    Cancer Res; 2003 Jun 15; 63(12):3352-5. PubMed ID: 12810670
    [Abstract] [Full Text] [Related]

  • 20. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.
    Sathyanarayana UG, Padar A, Huang CX, Suzuki M, Shigematsu H, Bekele BN, Gazdar AF.
    Clin Cancer Res; 2003 Dec 15; 9(17):6389-94. PubMed ID: 14695139
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.